These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 21429301)

  • 41. Cisplatin-resistant HeLa cells are resistant to apoptosis via p53-dependent and -independent pathways.
    Minagawa Y; Kigawa J; Itamochi H; Kanamori Y; Shimada M; Takahashi M; Terakawa N
    Jpn J Cancer Res; 1999 Dec; 90(12):1373-9. PubMed ID: 10665656
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Boswellic acid sensitizes gastric cancer cells to Cisplatin-induced apoptosis via p53-mediated pathway.
    Al-Bahlani S; Burney IA; Al-Dhahli B; Al-Kharusi S; Al-Kharousi F; Al-Kalbani A; Ahmed I
    BMC Pharmacol Toxicol; 2020 Sep; 21(1):64. PubMed ID: 32867831
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hyper-O-GlcNAcylation induces cisplatin resistance via regulation of p53 and c-Myc in human lung carcinoma.
    Luanpitpong S; Angsutararux P; Samart P; Chanthra N; Chanvorachote P; Issaragrisil S
    Sci Rep; 2017 Sep; 7(1):10607. PubMed ID: 28878262
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The ganglioside GM3 is associated with cisplatin-induced apoptosis in human colon cancer cells.
    Chung TW; Choi HJ; Kim SJ; Kwak CH; Song KH; Jin UH; Chang YC; Chang HW; Lee YC; Ha KT; Kim CH
    PLoS One; 2014; 9(5):e92786. PubMed ID: 24829158
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cisplatin-resistant prostate cancer model: Differences in antioxidant system, apoptosis and cell cycle.
    Gumulec J; Balvan J; Sztalmachova M; Raudenska M; Dvorakova V; Knopfova L; Polanska H; Hudcova K; Ruttkay-Nedecky B; Babula P; Adam V; Kizek R; Stiborova M; Masarik M
    Int J Oncol; 2014 Mar; 44(3):923-33. PubMed ID: 24366574
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of L-ascorbic acid on two cycles of cisplatin-induced DNA double-strand breaks and phosphorylation of p53 in the liver.
    Narayana K
    Exp Toxicol Pathol; 2012 Jul; 64(5):495-502. PubMed ID: 21111584
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cell-to-Cell Variation in p53 Dynamics Leads to Fractional Killing.
    Paek AL; Liu JC; Loewer A; Forrester WC; Lahav G
    Cell; 2016 Apr; 165(3):631-42. PubMed ID: 27062928
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of p53 and apoptosis in sensitization of cis-diamminedichloroplatinum antitumor activity by interleukin-1 in ovarian carcinoma cells.
    Song K; Fukushima P; Seth P; Sinha BK
    Int J Oncol; 1998 Feb; 12(2):299-304. PubMed ID: 9458352
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of irradiation and cisplatin on human glioma spheroids: inhibition of cell proliferation and cell migration.
    Fehlauer F; Muench M; Rades D; Stalpers LJ; Leenstra S; van der Valk P; Slotman B; Smid EJ; Sminia P
    J Cancer Res Clin Oncol; 2005 Nov; 131(11):723-32. PubMed ID: 16096850
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison between the antiproliferative effect and intracellular glutathione depletion induced by Casiopeína IIgly and cisplatin in murine melanoma B16 cells.
    Alemón-Medina R; Bravo-Gómez ME; Gracia-Mora MI; Ruiz-Azuara L
    Toxicol In Vitro; 2011 Jun; 25(4):868-73. PubMed ID: 21354300
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Restriction of cisplatin induction of acute apoptosis to a subpopulation of cells in a three-dimensional carcinoma culture model.
    Fayad W; Brnjic S; Berglind D; Blixt S; Shoshan MC; Berndtsson M; Olofsson MH; Linder S
    Int J Cancer; 2009 Nov; 125(10):2450-5. PubMed ID: 19670329
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Proteomic identification of chaperonin-containing tail-less complex polypeptide-1 gamma subunit as a p53-responsive protein in colon cancer cells.
    Lee SC; Chan J
    Cancer Genomics Proteomics; 2012; 9(2):101-8. PubMed ID: 22399500
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modulation of p53 expression by human recombinant interferon-alpha2a correlates with abrogation of cisplatin resistance in a human melanoma cell line.
    Davol PA; Goulette FA; Frackelton AR; Darnowski JW
    Cancer Res; 1996 Jun; 56(11):2522-6. PubMed ID: 8653690
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Integrin β4 reduces DNA damage‑induced p53 activation in colorectal cancer.
    Wu J; Zhao R; Lin J; Liu B
    Oncol Rep; 2018 Oct; 40(4):2183-2192. PubMed ID: 30106452
    [TBL] [Abstract][Full Text] [Related]  

  • 55. USP39 attenuates the antitumor activity of cisplatin on colon cancer cells dependent on p53.
    Yuan J; Li X; Zhang Y; Zhang G; Cheng W; Wang W; Lei Y; Song G
    Cell Biol Toxicol; 2023 Oct; 39(5):1995-2010. PubMed ID: 34822033
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chemotherapy Efficacy Is Dependent upon p53 Dynamics.
    Cancer Discov; 2016 Jun; 6(6):OF12. PubMed ID: 27125550
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cisplatin-induced apoptotic cell death in mouse hybrid neurons is blocked by antioxidants through suppression of cisplatin-mediated accumulation of p53 but not of Fas/Fas ligand.
    Park SA; Choi KS; Bang JH; Huh K; Kim SU
    J Neurochem; 2000 Sep; 75(3):946-53. PubMed ID: 10936175
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Targeting protein-trafficking pathways alters melanoma treatment sensitivity.
    Huang ZM; Chinen M; Chang PJ; Xie T; Zhong L; Demetriou S; Patel MP; Scherzer R; Sviderskaya EV; Bennett DC; Millhauser GL; Oh DH; Cleaver JE; Wei ML
    Proc Natl Acad Sci U S A; 2012 Jan; 109(2):553-8. PubMed ID: 22203954
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Electromagnetic Field Could Protect SH-SY5Y Cells Against Cisplatin Cytotoxicity, But Not MCF-7 Cells.
    Mahmoudinasab H; Saadat M
    DNA Cell Biol; 2018 Apr; 37(4):330-335. PubMed ID: 29446648
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Suppression of heat-induced p53 accumulation and activation by CDDP or x-rays in human glioblastoma cells.
    Matsumoto H; Hayashi S; Shioura H; Ohtsubo T; Nishida T; Kitai R; Ohnishi T; Kano E
    Int J Oncol; 1998 Oct; 13(4):741-7. PubMed ID: 9735404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.